Image only for representational purposes. Reuters photo.
Tribune News Service
New Delhi, January 3
The WHO on Sunday welcomed the emergency use authorization given to COVID-19 vaccines in India, the first in the South-East Asia Region.
Also read: CDSCO approves Covishield, COVAXIN for restricted emergency use in India
‘Covishield’ ready to roll out in coming weeks: Poonawalla
Bharat Biotech recruits 23,000 volunteers for COVID-19 vaccine trials
Approval for vaccines accelerates India’s journey to be COVID-free, says Modi
“This decision taken today by India will help intensify and strengthen the fight against COVID-19 pandemic in the Region.
(Click here for the latest developments on Covid-19 epidemic)
The use of the vaccine in prioritized populations, along with the continued implementation of other public health measures and community participation will be important in reducing the impact of COVID-19," said Dr Poonam Khetrapal Singh, Regional Director WHO South-East Asia Region
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Salman Khan house firing case: Accused attempts suicide in lock-up, dies at hospital in Mumbai
Deceased was accused of supplying weapons to shooters who op...
At least 100 schools receive bomb threats in Delhi NCR; found nothing after checks, say police
The schools are evacuated after local police are informed ab...
Plea in Supreme seeking expert panel to examine possible side effects, risk factors of Covishield vaccine
It said a large number of Covishield doses were administered...
Election Commission revises protocol for handling, storage of symbol loading unit of EVM and VVPAT after Supreme Court order
Top poll body directs all state chief electoral officers to ...
Dalvir Goldy joins AAP day after quitting Congress; Bhagwant Mann calls him ‘good, promising’ candidate
He quit the Congress on Tuesday, days after expressing "disp...
